People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoLucid Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $60.0M | $1.3B | 2011 |
Thomas P. Mathers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas P. Mathers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jesse I. Treu | 1 | 5 |
| Arthur M. Pappas | 1 | 3 |
| Richard J. Markham | 1 | 2 |
| Nadia M. Rupniak | 1 | 1 |
| James F. White | 1 | 1 |
| Daniel L. Boeglin | 1 | 1 |
| Richard I Markham | 1 | 1 |
| Bernice C. Kuca | 1 | 1 |
| Martin C. Edwards | 1 | 1 |
| Timothy C. Gupton | 1 | 1 |
| Luc C. Marengere | 1 | 1 |
| Nadia C. Rupniak | 1 | 1 |
| Mathers P. Thomas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.